Manfred Koegl

Company: Boehringer Ingelheim

Job title: Director

Seminars:

Target Protein Degradation & Drug Discovery: Lessons Learnt 11:30 am

Tumor cell dependence on SMARCA2 in SMARCA4 mutant tumours: an opportunity for PROTAC drug discovery Steep structure property relationships in working towards bioavailability Discovery of the first selective and orally bioavailable SMARCA2 degrader BI-0284Read more

day: Day 2 AM - Stream B